Does kidney transplantation actually help older patients live longer than dialysis?
Yes, for most older patients, kidney transplantation leads to significantly better long-term survival compared to staying on dialysis, but the benefit takes time to appear. A matched-pair study of patients over 70 from Australia and New Zealand found that transplant recipients initially had a higher death rate in the first 9 months (1.9 deaths per 100 patient-years vs. 0.3 for dialysis), mainly due to infections. However, after that early period, the survival advantage became clear: over a median follow-up of 1.7 years, mortality was 38% lower for transplant recipients, and at 5 years, 80% of transplant patients were alive versus only 53% of those on dialysis [1]. This pattern — early risk, later reward — is consistent across multiple studies. A single-center study of patients over 70 reported 1-year graft survival of 92.6% and 5-year graft survival of 53.8%, with death-censored graft survival (excluding deaths with a functioning kidney) at 100% at 1 year and 80.8% at 5 years [10]. Another study of patients over 65 found 1-, 3-, and 5-year patient survival rates of 94%, 81%, and 76%, respectively [11]. These figures are comparable to or better than typical dialysis survival rates for this age group.
The survival benefit is not uniform across all older patients. The same Australian study found that recipients of living donor or standard criteria deceased donor kidneys gained an immediate survival advantage over dialysis, while those who received expanded criteria donor kidneys (from older or less healthy donors) faced an elevated risk of death for the first 17 months before the benefit emerged [1]. This means the type of kidney available matters greatly for older patients. Additionally, a study comparing older transplant recipients to matched patients with chronic kidney disease (not on dialysis) found that transplant recipients did not have a higher risk of death or cardiovascular events, but they did have higher risks of kidney failure and infection-related hospitalizations [5]. This suggests that while transplantation restores kidney function, it introduces new risks from immunosuppression.
Importantly, the survival advantage of transplantation over dialysis is not just about living longer — it's also about quality of life. An interview study with patients over 65 found that their health outcome priorities were mostly related to quality of life, not just survival [6]. While the quantitative studies here focus on survival, the consistent message is that for carefully selected older patients, transplantation offers a real chance at extended life, though the first year requires close monitoring for infections and complications.
What are the specific risks older patients face with transplantation versus dialysis?
The main trade-off is clear: transplantation offers better long-term survival but carries higher short-term risks, particularly from infections and surgical complications. In the Australian study of patients over 70, the early excess deaths in transplant recipients were driven by infection-related deaths (1.9 vs. 0.3 per 100 patient-years) [1]. A study of patients over 65 found that 50% experienced a bacterial infection in the first year after transplant, and 56.3% had delayed graft function (the kidney didn't start working immediately) [3]. Another study comparing older transplant recipients to matched chronic kidney disease patients found that transplant recipients had a nearly 4-fold higher risk of infection-related hospitalizations (hazard ratio 3.91) and a 3.5-fold higher risk of progression to kidney failure [5]. These numbers underscore that immunosuppression, while necessary to prevent rejection, leaves patients vulnerable to serious infections.
Frailty and functional status are critical factors that influence outcomes. A study of a geriatric co-management program for older transplant candidates found that patients who were listed for or received a transplant had significantly higher scores on instrumental activities of daily living (IADL) — tasks like managing finances, shopping, and using transportation — compared to those deemed ineligible [7]. This suggests that a patient's ability to function independently is a key factor in transplant teams' decisions. Frailty itself is common in older patients with advanced kidney disease: a study of patients over 65 with stage 4 or 5 chronic kidney disease found that 51.3% were frail and 47.3% were pre-frail, with higher phosphate levels independently associated with frailty [9]. This means many older dialysis patients are already frail before they even consider transplantation, which can increase post-transplant risks.
The risk of death from COVID-19 is also higher in transplant recipients compared to dialysis patients. A study from Pakistan found that among patients who contracted COVID-19, the 28-day probability of death was higher in kidney transplant recipients than in hemodialysis patients, and transplant patients had higher clinical frailty scores [8]. This highlights that in a pandemic context, the immunosuppressed state of transplant recipients can be a serious disadvantage. Additionally, tuberculosis is more common in both dialysis and transplant patients, with a 1-year survival of 78% after diagnosis, and age was an independent risk factor for poorer survival [12]. These infection risks are a major consideration for older patients, who may have weaker immune systems to begin with.
Do older patients actually get offered transplantation as often as younger ones?
No, older patients are significantly less likely to be placed on the transplant waiting list or to receive a transplant, even when they might benefit. A large US study of nearly 2.5 million dialysis patients found that those aged 65 and older were 82% less likely to be listed for a first kidney transplant compared to those aged 18-64 (adjusted hazard ratio 0.18), and even when listed, they were 12% less likely to actually receive a transplant [4]. This age disparity has been persistent over decades, though it has narrowed somewhat for first-time listings since the 2014 kidney allocation system change [2][4]. Another US study focusing on racial disparities found that Black patients aged 65-80 were 20% less likely to be waitlisted than White patients of the same age, showing that age and race together create even greater barriers [2].
The reasons for this disparity are complex. The interview study with patients, relatives, and healthcare professionals found that older patients' priorities were often about quality of life, while healthcare professionals focused on determining transplant eligibility first, then providing information [6]. This mismatch can lead to older patients not being fully informed about transplantation as an option, or being steered toward dialysis without a thorough discussion. The study also noted that older patients varied widely in how much they wanted to be involved in decision-making — some wanted to lead, others preferred to follow the doctor's advice [6]. This suggests that a one-size-fits-all approach to discussing treatment options is inadequate.
Despite these barriers, the evidence strongly supports that transplantation should be considered for older patients who are medically suitable. A study from Thailand, a middle-income country with universal health coverage, reported that only 6% of dialysis patients receive a transplant, and the average age of transplant recipients is 47 years — far younger than the older population that might benefit [13]. In the Netherlands, the dialysis incidence has been decreasing most sharply among patients over 75, partly due to increased pre-emptive transplantation and a shift toward conservative care for the frailest [14]. This suggests that healthcare systems are beginning to recognize that not all older patients are good candidates for dialysis, let alone transplantation, and that individualized decision-making is key.
About These Sources
This answer is built on 14 peer-reviewed studies — published from 2022 to 2026, 4 from 2024 or later, 7 in Q1 journals, collectively cited 133 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 62 papers retrieved from a database of over 500 million.
Sources used in this answer
Survival after kidney transplantation compared with ongoing dialysis for people over 70 years of age: A matched-pair analysis
In a matched-pair analysis of patients over 70, transplant recipients had higher early mortality (first 9 months) but then a progressive survival advantage, with 5-year survival of 80% vs. 53% for dialysis patients.
Race, Age, and Kidney Transplant Waitlisting Among Patients Receiving Incident Dialysis in the United States
In a US cohort of 439,455 dialysis patients, Black patients aged 65-80 were 20% less likely to be waitlisted than White patients of the same age, showing intersectional disparities.
Kidney Transplantation in Elderly Recipients: Five-Year Experience
In a single-center study of patients over 65, 1-, 3-, and 5-year patient survival after transplant was 100%, 97.6%, and 79.2%, similar to younger recipients, but 50% had bacterial infections in the first year.
Age Disparities in Access to First and Repeat Kidney Transplantation
In a US registry study of 2.5 million patients, those aged 65+ were 82% less likely to be listed for a first kidney transplant than those 18-64, and 12% less likely to receive one once listed.
Clinical Benefit and Remaining Risks of Kidney Transplantation in Older Patients: A Matched Comparison With CKD Patients.
Older transplant recipients had similar risks of death and cardiovascular events as matched chronic kidney disease patients, but a 3.9-fold higher risk of infection-related hospitalizations.
Kidney transplantation or dialysis in older adults—an interview study on the decision-making process
In interviews with patients over 65, relatives, and healthcare professionals, older patients prioritized quality of life, while professionals focused on transplant eligibility and medical outcomes.
GERIATRIC RENAL TRANSPLANT CO-MANAGEMENT: EVALUATION OF FRAIL OLDER ADULTS FOR TRANSPLANT ELIGIBILITY
In a geriatric co-management program, older patients who were listed for transplant had significantly higher instrumental activities of daily living scores than those deemed ineligible.
COVID-19 in Dialysis and Kidney Transplant Patients
Among COVID-19-positive patients, kidney transplant recipients had a higher 28-day probability of death than hemodialysis patients, and higher clinical frailty scores.
Phosphate is associated with frailty in older patients with chronic kidney disease not on dialysis.
In patients over 65 with advanced chronic kidney disease, 51.3% were frail and higher serum phosphate was independently associated with frailty (odds ratio 3.38).
Kidney Transplant Outcomes in Recipients Over the Age of 70
In patients over 70 receiving a kidney transplant, 1-year graft survival was 92.6% and 5-year graft survival was 53.8%, with death-censored graft survival at 100% and 80.8%.
Graft and Patient Survival in Kidney Transplant Recipients Over the Age of Sıxty-Five
In patients over 65 who received a living donor kidney transplant, 1-, 3-, and 5-year patient survival was 94%, 81%, and 76%, respectively, over a median follow-up of 7-125 months.
Diagnosis of tuberculosis in dialysis and kidney transplant patients
In a 12-year review of tuberculosis in dialysis and transplant patients, 1- and 5-year survival after diagnosis was 78% and 61%, with age as an independent risk factor for poorer survival.
Dialysis and kidney transplant practices and challenges in Thailand
In Thailand, only 6% of dialysis patients receive a kidney transplant, and the average transplant recipient age is 47 years, despite universal health coverage for kidney failure.
Decreasing incidence of dialysis in older patients in The Netherlands as compared with other European countries: an international perspective
In the Netherlands, dialysis incidence has decreased most sharply among patients over 75 (annual decline of 3.2%), partly due to increased pre-emptive transplantation and conservative care.